Infection Surveillance Solutions Market Analysis

The global infection surveillance solutions market is estimated to be valued at US$ 683.8 million in 2023 and is expected to exhibit a CAGR of 14.2% during the forecast period (2023-2030).

Analysts’ Views on Global Infection Surveillance Solutions Market:

The global infection surveillance solutions market's growth can be hindered by inadequate data management. Implementation of automated surveillance systems for the management of healthcare-associated infections such as surgical site infection, blood stream infection, etc. is expected to drive the global infection surveillance solutions market over the forecast period. For instance, according to the data published in ScienceDirect journal, in July 2021, a guideline document was written by a task force formed in March 2019 within the PRAISE network (Providing a Roadmap for Automated Infection Surveillance in Europe), gathering experts in healthcare-associated infections surveillance from ten European countries that are aware and provide an overview of the key e-health aspects of implementing an automated surveillance system of hospital acquired infections in a clinical environment to support the infection prevention and control team

Figure 1. Global Infection Surveillance Solutions Market Share (%), by Infection Type, 2023

Global Infection Surveillance Solutions Market – Driver

Increasing awareness campaign for the urinary tract infection

Increasing awareness campaign by key market players is expected to drive the infection surveillance market over the forecast period. For instance, Urovant Sciences, a pharmaceutical company, announced that it had launched a new multichannel education campaign that aims to spread awareness among people about the urinary tract infection and guide them through proper management and prevention of urinary tract infection

Figure 2. Global Infection Surveillance Solutions Market Value (US$ Million), by Region, 2023

Global Infection Surveillance Solutions Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global infection surveillance solutions market over the forecast period. North America holds 45.1% of the market share due to the increasing prevalence of hospital-acquired infections (HAIs) in the region. According to data published by the National Center for Biotechnology Information, in July 2020, the prevalence of hospital-acquired infections (HAIs) was 30%

Global Infection Surveillance Solutions Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global infection surveillance solutions market. For instance, in September 2020, Stanford University along with the Chan Zuckerberg Biohub, a research organization and a group of collaborators announced that they had developed a low-cost system to collect samples for COVID-19 testing and monitor populations for the disease.

Infection Surveillance Solutions Market Report Coverage

Report Coverage	Details
Base Year:	2022	Market Size in 2023:	US$ 683.8 Mn
Historical Data for:	2017 to 2021	Forecast Period:	2023 to 2030
Forecast Period 2023 to 2030 CAGR:	14.2%	2030 Value Projection:	US$ 1,732.3 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product and Services: Software (On-Premises, Web-Based), Services (Support & Maintenance, Training & Consulting By Infection Type: Surgical Site Infections, Blood Stream Infections, Urinary Tract Infections  By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other (Specialty Center, etc.)
Companies covered:	Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences and Premier
Growth Drivers:	Increasing prevalence of infectious diseases
Restraints & Challenges:	Inadequate data management and computing resources

Global Infection Surveillance Solutions Market Segmentation:

The global infection surveillance solutions market report is segmented into Product and Services, Infection Type, End User, and Region

Based on Products and Services, the market is segmented into software and services. Out of which, the software segment is expected to hold a dominant position in the infection surveillance solutions market during the forecast period and this is attributed to the increasing usage of surveillance software for management.

Based on Infection Type, the market is segmented into surgical site infections, blood stream infections, and urinary tract infections. Out of which, the surgical site infections segment is expected to hold a dominant position in the infection surveillance solutions market during the forecast period and this is attributed to the increasing prevalence of surgical site infection.

Based on End User, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others (specialty centers, etc.). Out of which, the hospital segment is expected to dominate the market over the forecast period and this is attributed to the increase in the number of new hospitals for the management of infection over the forecast period.

Among all segmentation, the infection type segment has the highest potential due to the increasing prevalence of surgical site infection over the forecast period. For instance, according to the data published by the Agency for Healthcare and Research and Quality, in September 2019, surgical site infections occur in 4% of all patients undergoing surgical procedures and 3% of patients leading to the cause of readmissions to the hospital following surgery.

Global Infection Surveillance Solutions Market Cross Sectional Analysis:

In infection type segment, surgical site infections hold a dominant segment in North America region due to the increasing prevalence of surgical site infection. For instance, in June 2021, A hospital-based analytic cross-sectional study was conducted based on the review of medical records of 1069 women in Ethiopia city to estimate the prevalence of surgical site infection and identify the factors associated with surgical site infection. It was estimated that the prevalence of surgical site infection was 12.3% which was relatively high.

Global Infection Surveillance Solutions Market: Key Developments

Effective use of infection surveillance software to support effective infection prevention and control for managing COVID-19 is expected to drive the global infection surveillance solutions market growth over the forecast period. For instance, according to the data published by the British Journal of Nursing, the Dorset County Hospital NHS Foundation Trust in Dorchester used digital solutions for infection prevention and control of COVID-19 infection during the pandemic and implemented specialized clinical surveillance software

Global Infection Surveillance Solutions Market: Key Trends

Increasing prevalence and factors associated with surgical site infection is expected to drive the infection surveillance solutions market growth over the forecast period.

Increasing prevalence of surgical site infection needs effective factors for the management of surgical site infection which is expected to drive the infection surveillance market growth over the forecast period. For instance, in February 2021, according to the data published by Frontiers Journal, an analytical study of 384 operated patients was conducted at the National University Hospital Centre Hubert Koutoukou Maga in Cotonou. Hence, it was stated that the prevalence of surgical site infections was 7.81%.

Global Infection Surveillance Solutions Market: Restraint

Inadequate data management and computing resources

The global infection surveillance solutions market can be hindered by inadequate data management and computing resources. For instance, in August 2022, according to the data published by National Center for Biotechnology Information, a study was conducted in Tanzania, for surveillance management. It resulted that the surveillance was not conducted proper enough for data entry, due to which patients were unable to analyze the surveillance’s current data and previous data due to a lack of consistency

Global Infection Surveillance Solutions Market - Key Players

Major players operating in the global infection surveillance solutions market include Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences and Premier

Global Infection Surveillance Solutions Market– Insights

Infection surveillance data is used to measure and prevent patients and health workers from being harmed by avoidable infections. Infection prevention and control affects all aspects of health care, including hand hygiene, surgical site infections, injection safety, antimicrobial resistance, and hospitals operating during and outside of emergencies.